TIM4 expression by dendritic cells mediates uptake of tumor-associated antigens and anti-tumor responsesNicoletta Caronni, Federica Benvenuti, Regine J. Dress et al.|Nature Communications|2021Cited by 71
Dendritic cell-targeted therapy expands CD8 T cell responses to bona-fide neoantigens in lung tumorsLucía López, Federica Benvenuti, Luciano Gastón Morosi et al.|Nature Communications|2024Cited by 44
The Rab32 small GTPase is required for efficient cross-priming of CD8 <sup>+</sup> T cells against cell-associated antigens by XCR1 <sup>+</sup> type 1 DCs <i>in vivo</i>Naman Tandon, Pierre Guermonprez|bioRxiv (Cold Spring Harbor Laboratory)|2025Cited by 1